{"id":556558,"date":"2021-08-06T18:30:04","date_gmt":"2021-08-06T18:30:04","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=556558"},"modified":"2021-08-06T18:30:04","modified_gmt":"2021-08-06T18:30:04","slug":"patient-monitoring-devices-market-worth-551-billion-by-2025-major-players-are-edwards-lifesciences-corporation-us-omron-corporation-japan","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/patient-monitoring-devices-market-worth-551-billion-by-2025-major-players-are-edwards-lifesciences-corporation-us-omron-corporation-japan_556558.html","title":{"rendered":"Patient Monitoring Devices Market worth $55.1 billion by 2025 | Major Players are Edwards Lifesciences Corporation (US), OMRON Corporation (Japan)"},"content":{"rendered":"
\n
\"Patient<\/a><\/div>\n
\n
The major players in the patient monitoring devices market are Abbott Laboratories (US), HILL-ROM HOLDINGS, INC. (US), Dr\u00e4gerwerk AG & Co. KGaA (Germany), Edwards Lifesciences Corporation (US), OMRON Corporation (Japan), Masimo Corporation (US), Compumedics Limited (Australia).<\/div>\n<\/div>\n<\/div>\n
Patient Monitoring Devices Market Research Report Gives in Detailed Analysis of Industry Segments, Opportunities, Growth and Size That Will Help Your Business Grow.<\/div>\n

According to the new market research report “<\/strong>Patient Monitoring Devices Market<\/a> by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitoring, MCOT, ECG, ICP, ILRs, Blood Glucose Monitoring, Blood Pressure Monitor), End-User (Hospitals, ASCs) – Global Forecast to 2025″,<\/strong> published by MarketsandMarkets™, the Patient Monitoring Devices Market is projected to reach USD 55.1 billion<\/span> by 2025 from USD 36.4 billion<\/span> in 2020, at a CAGR of 8.6% during the forecast period.<\/p>\n

Browse in-depth TOC on <\/em>“Patient Monitoring Devices Market”
328 – Tables
39 – Figures
354 – Pages<\/strong><\/p>\n

Download PDF Brochure: <\/strong>https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=678<\/a><\/p>\n

The growth of this market is mainly driven by the growing number of hospitals across major markets, increasing awareness about vital parameter monitoring for treatment and diagnosis of chronic diseases coupled with the increasing adoption of wearable and wireless patient monitoring devices for homecare. Moreover, rising R&D investments by the key players operating in the market to develop advanced monitoring devices coupled with growing funding & grants for commercialization and development of monitoring devices are other important factors to drive the market growth in the near future.<\/p>\n

The ECG devices sub segment of cardiac monitoring devices products to hold major market share by 2025<\/strong><\/p>\n

Based on the product, the patient monitoring device market is segmented into blood glucose monitoring systems, cardiac monitoring devices, multiparameter monitoring devices, respiratory monitoring devices, temperature monitoring devices, hemodynamic\/pressure monitoring devices, fetal and neonatal monitoring devices, neuromonitoring devices, weight monitoring devices and other patient monitoring devices. The cardiac monitoring devices products segment is further divided into ECG devices, event monitors, implantable loop recorders (ILRs), mobile cardiac telemetry (MCT) monitors, and smart\/wearable ECG monitors. Among the cardiac monitoring devices products, the ECG devices segment held a major share of the market in 2019. The wide applications of ECG devices in CVD management are a major factor contributing to the growth of this market segment. Other factors supporting market growth include the low cost of ECG devices and the simplicity, easy-to-access nature, and compact & ergonomic design of these devices.<\/p>\n

Based on product, the blood glucose monitoring systems segment is expected to account for the largest share of the patient monitoring devices market in 2019<\/strong><\/p>\n

Based on type, the blood glucose monitoring systems market has been segmented into the self-monitoring blood glucose systems and continuous glucose monitoring system. Among these, the self-monitoring blood glucose systems sub-segment dominated the market in 2019. The major share of the segment is attributed to the rising adoption of integrated blood glucose monitoring systems in developing as well as developed countries. New products have been introduced in the market that allow for easier result interpretation. LifeScan, for example, launched the OneTouch Verio Flex in 2016, which comes with the ColorSure technology to determine if blood glucose levels are low or high. Many manufacturers offer smartphone-connected meters that allow information transfer using Bluetooth.<\/p>\n

The hospital segment is expected to register the highest growth rate during the forecast period<\/strong><\/p>\n

Based on end user, the patient monitoring devices market has been segmented into the hospitals, ambulatory surgery centers, home care settings and other end users. Significant market growth and large share of hospital segment can primarily be attributed to the presence of advanced ICUs and emergency wards in hospitals and the increasing number of surgical procedures.

Request Sample Pages: <\/strong>https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=678<\/a> 

North America<\/span> is expected to dominate the global patient monitoring market in 2019<\/strong><\/p>\n

North America<\/span>, comprising the US and Canada<\/span>, accounted for the largest share of the patient monitoring devices market in 2019. Increasing number of clinical trials validating patient monitoring devices and a growing number of approvals for patient monitoring. Are the major factors driving market growth in North America<\/span>. Customers in North America<\/span> are moving towards homecare patient monitoring, which requires non-invasive patient monitoring devices. This trend will have a positive impact on the market.<\/p>\n

Abbott Laboratories (US), HILL-ROM HOLDINGS, INC. (US), Drägerwerk AG & Co. KGaA (Germany<\/span>), Edwards Lifesciences Corporation (US), OMRON Corporation (Japan<\/span>), Masimo Corporation (US), Compumedics Limited (Australia<\/span>), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China<\/span>), Nihon Kohden Corporation (Japan<\/span>), Natus Medical (US), Medtronic plc (Ireland<\/span>), Koninklijke Philips N.V. (Netherlands<\/span>), GE Healthcare (US), Getinge AB (Sweden<\/span>), Boston Scientific Corporation (US), Dexcom, Inc. (US), Nonin (US), BIOTRONIK (Germany<\/span>), SCHILLER (Switzerland<\/span>), and BioTelemetry, Inc. (US), among othersare some of the major players operating in the global patient monitoring devices market.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> MarketsandMarkets<\/a>
Contact Person:<\/strong> Mr. Aashish Mehra
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 18886006441
Address:<\/strong>630 Dundee Road Suite 430
City:<\/strong> Northbrook
State:<\/strong> IL 60062
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.marketsandmarkets.com\/Market-Reports\/patient-healthcare-monitoring-systems-devices-market-678.html<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

The major players in the patient monitoring devices market are Abbott Laboratories (US), HILL-ROM HOLDINGS, INC. (US), Dr\u00e4gerwerk AG & Co. KGaA (Germany), Edwards Lifesciences Corporation (US), OMRON Corporation (Japan), Masimo Corporation (US), Compumedics Limited (Australia). Patient Monitoring Devices Market … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,411,403],"tags":[],"class_list":["post-556558","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Technology","category-UK"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/556558","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=556558"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/556558\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=556558"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=556558"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=556558"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}